Core Viewpoint - China Xuyang Group (01907) announced the transfer of 4.503 million shares from its inventory to the trustee of the share incentive plan adopted on May 30, 2025, with the shares to be held by the trustee until they are awarded to the beneficiaries of the plan [1] Group 1 - The company will transfer 4.503 million shares to the trustee on February 11, 2026 [1] - The shares are part of a share incentive plan that was adopted on May 30, 2025 [1] - The trustee will hold the shares until they are awarded to the beneficiaries [1]

FF305 FF305 B. 贖回/購回股份 (擬註銷但截至期終結存日期尚未註銷) (註5及6) 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 中國旭陽集團有限公司 呈交日期： 2026年2月11日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 01907 | 說明 | 股份 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包 ...

Core Viewpoint - The overall order and environment of the caprolactam market have improved due to industry collaboration and recovering market demand, with product prices rising from 8,050 yuan/ton in early November 2025 to 9,900 yuan/ton by February 11, 2026, driven by China Xuyang Group's innovation and capacity expansion [1] Group 1: Capacity Expansion and Technological Innovation - China Xuyang Group has achieved significant capacity expansion in caprolactam, reaching a total capacity of 810,000 tons/year, with a market share of approximately 9.6% [2] - The Cangzhou Park, as the flagship production base, has developed a complete industrial chain system around caprolactam, with a production capacity of 510,000 tons/year [3] Group 2: Collaborative Coupling and Industry Chain Extension - The Dongming Park has also completed capacity upgrades, achieving an annual production capacity of 300,000 tons of caprolactam, enhancing collaboration between the Cangzhou and Dongming parks [4] - The company has developed a proprietary process for direct preparation of hexamethylenediamine, breaking foreign technology barriers and creating a complete set of intellectual property rights, which will support further development in high-end nylon fields [4] Group 3: Strategic Expansion and Cooperative Development - Looking ahead, the company plans to continue leveraging the synergistic effects of its two major parks, focusing on disruptive core technology and expanding applications in elastomer nylon and high-temperature nylon [5] - The company aims to establish a national-level nylon new material industry base by integrating the caprolactam-nylon full industry chain through deep cooperation with downstream enterprises [5]

Core Viewpoint - The overall order and environment of the caprolactam market have improved due to industry collaboration and recovering market demand, with product prices rising from 8,050 RMB/ton in early November 2025 to 9,900 RMB/ton by February 11, 2026, driven by China Xuyang Group's innovation and capacity expansion [1] Group 1: Capacity Expansion and Technological Innovation - China Xuyang Group has achieved significant breakthroughs in cost control and production efficiency through capacity expansion and technological upgrades, reaching a total caprolactam production capacity of 810,000 tons/year, with a market share of approximately 9.6% [2] - The Cangzhou Park serves as the flagship base for caprolactam production, with a total annual capacity of 510,000 tons, supported by a complete industrial chain established through major expansions from 2019 to 2022 [3] Group 2: Industrial Chain Extension and New Market Opportunities - The Dongming Park has also completed capacity upgrades, achieving an annual production capacity of 300,000 tons of caprolactam, enhancing collaboration between the two parks and laying a solid foundation for the development of new nylon materials [4] - The company has developed a proprietary process for direct preparation of hexamethylenediamine from caprolactam, breaking foreign technology barriers and creating a complete set of intellectual property rights, which will support further development into high-end nylon fields [4] Group 3: Strategic Development and International Competitiveness - Looking ahead, the company plans to leverage the synergistic effects of its two major parks, focusing on both independent research and technology introduction to tackle disruptive core technologies in the nylon sector [5] - The company aims to establish a national-level nylon new materials industry base by fostering deep cooperation with downstream enterprises, creating a comprehensive caprolactam-nylon industrial chain [5]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中國旭陽集團有限公司 呈交日期: 2026年2月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01907 | 說明 | 股份 | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | 10,000,000,000 | | HKD | | 0.1 HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 10,000,000,000 | HKD | | 0.1 HKD | | 1,000,000,000 | 本月底法定/註冊股本總額： H ...

Group 1 - The core viewpoint of the articles indicates that the coking coal sector in both Hong Kong and A-shares has collectively risen due to market expectations regarding demand and inflation, suggesting a potential turning point for the sector as overall valuations are at historical lows [1] - The report highlights that the rise in the coking coal sector is primarily driven by a collective resonance in the resource sector, with coal and coking coal being positively influenced by the performance of non-ferrous metals and oil [1] - The recommended stock for investment is China Xuyang Group (01907) [1] Group 2 - For 2025, the total coking coal production is projected to be 504 million tons, reflecting a year-on-year increase of 2.9%, while crude steel production is expected to be 960 million tons, showing a year-on-year decline of 4.4% [1] - In the first half of 2025, coking coal prices are expected to decline due to relaxed supply, weak demand, and the impact of imported Mongolian coal on coal prices [1] - The implementation of the "overproduction check" policy in the second half of 2025 is anticipated to restrict excessive production by coal mining companies, leading to a rebound in coal prices and subsequently coking coal prices [1] Group 3 - In 2026, it is crucial to monitor the policy direction, including the ongoing enforcement of the coal "overproduction check" policy and the execution of capacity replacement and shutdown policies for non-compliant capacities in the coking coal industry [2] - Attention should also be given to the recovery of the downstream real estate sector, as demand from real estate will significantly impact the coking coal industry [2] - Current market expectations indicate a certain level of recovery in the real estate sector, which could influence the coking coal industry positively [2]

Group 1 - The core viewpoint of the report is that the coke sector in both Hong Kong and A-shares has collectively risen due to market expectations regarding demand and inflation, indicating a potential turning point as the overall valuation of the coke sector is at a historical low [1] - The main reason for the sector's rise is attributed to the collective resonance of resource sectors, with the coal and coke sectors being significantly boosted by the performance of non-ferrous metals and oil [1] - The recommended stock for investment is China Xuyang Group (01907) [1] Group 2 - For 2025, the total coke production is projected to be 504 million tons, representing a year-on-year increase of 2.9%, while downstream crude steel production is expected to be 960 million tons, reflecting a year-on-year decrease of 4.4% [1] - In the first half of 2025, due to relaxed supply, weak demand, and the impact of imported Mongolian coal on coal prices, coke prices continued to decline [1] - The "overproduction check" policy was introduced in the second half of 2025 to limit excessive production by coal mining companies, leading to a rebound in coal prices and subsequently in coke prices [1] Group 3 - By December 2025 and January 2026, coal enterprises began to resume production, but the demand side remained weaker than expected, resulting in a decline in both coal and coke prices [1] - As of January 20, 2026, the price of premium metallurgical coke was 1,346.4 yuan per ton, down 50 yuan per ton from the beginning of the month [1] - In 2026, attention should be paid to the execution strength of policies regarding coal "overproduction checks" and the replacement of coke industry capacity, as well as the shutdown of non-compliant capacity [2]

Group 1 - The company, China Xuyang Group (01907), announced a share award plan to grant a total of 4.503 million shares to 600 employees, pending acceptance by the recipients [1] - The share award plan was adopted during the company's annual general meeting held on May 30, 2025 [1] - The effective date for the share grant is set for January 22, 2026, contingent upon acceptance by the designated employees [1]

Core Viewpoint - China Xuyang Group (01907) announced a share award plan to grant a total of 4.503 million shares to 600 employees, pending acceptance by the recipients [1] Group 1 - The share award plan will be implemented on January 22, 2026 [1] - The plan was adopted during the company's annual general meeting held on May 30, 2025 [1]

Core Viewpoint - China Xuyang Group (01907.HK) announced the grant of a total of 4.503 million shares to 600 employees under the share incentive plan adopted at the annual general meeting held on May 30, 2025, effective January 22, 2026, pending acceptance by the grantees [1] Group 1 - The company will grant a total of 4.503 million shares as part of its share incentive plan [1] - The share grant is directed towards 600 employees of the group [1] - The plan was adopted during the annual general meeting on May 30, 2025 [1]